Emcure Pharmaceuticals Limited (NSE: EMCURE)

Emcure Pharmaceuticals Revenue

Emcure Pharmaceuticals had revenue of 20.02B INR in the quarter ending September 30, 2024, with 20.38% growth. This brings the company's revenue in the last twelve months to 72.56B, up 13.13% year-over-year. In the fiscal year ending March 31, 2024, Emcure Pharmaceuticals had annual revenue of 66.58B with 11.23% growth.

• Revenue (ttm): 72.56B
• Revenue Growth: +13.13%
• P/S Ratio: 3.58
• Revenue / Employee: 6.69M
• Employees: 10,852
• Market Cap: 269.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	66.58B	6.72B	11.23%
Mar 31, 2023	59.86B	1.30B	2.23%
Mar 31, 2022	58.55B	8.22B	16.33%
Mar 31, 2021	50.33B	-150.80M	-0.30%
Mar 31, 2020	50.49B	3.31B	7.02%